Psychedelic therapy is a clinically guided approach that combines the careful administration of regulated psychedelic compounds with professional therapeutic support. Unlike recreational use, it takes place within a carefully designed framework built on preparation, the therapeutic session itself, and integration — and it is showing remarkable promise for a wide range of mental health conditions.
Interest in psychedelic therapy is growing across Canada, with health professionals and clients in cities like Edmonton, Calgary, and beyond increasingly asking the same question: how does it actually work?
The Three Phases of Psychedelic Therapy
Every evidence-based psychedelic therapy protocol involves three core phases:
- Preparation: Before any session begins, of course our goal is for you and your therapist to build rapport, establish your therapeutic goals, and explore your history, intentions, and any contraindications (anything that could have an effect on the medically supervised session). This phase usually spans one to several sessions (or longer, if you’re working with your own therapist, which we encourage!) and is essential for a safe and productive experience.
- The Medically Supervised Session: In a calm, intentionally designed clinical setting, you’ll be administered the psychedelic compound under the supervision of a trained practitioner. Sessions can last several hours, during which you may process deeply held emotions, memories, and patterns — often accessing material that is difficult to reach through conventional talk therapy alone.
- Integration: Following the session, you and your therapist work together to make meaning of what arose. Integration is widely regarded as one of the most important parts of the process, as it is during this phase that lasting psychological shifts are integrated.
What Happens in the Brain
Psychedelic compounds work primarily through activity at serotonin receptors in the brain — particularly the 5-HT2A receptor — leading to increased neuroplasticity, or the brain’s ability to form new connections. Research has shown that certain psychedelic compounds can suppress the Default Mode Network (DMN), a set of brain regions associated with self-referential thinking, rumination, and patterns of thought that underlie common mental health conditions like depression and anxiety.
This temporary shift in brain activity can allow for new perspectives, emotional breakthroughs, and a loosening of rigid thought patterns — all within a supported, therapeutic clinical environment.
The Role of the Therapist
In psychedelic therapy, the therapist does not disappear into the background — they play a central role before, during, and after your medically supervised session. Their training, presence, and attunement are critical to ensuring you feel safe throughout the process. The concept of “set and setting” — the mindset you bring into the session, and the environment in which it takes place — is well-established in the clinical literature as a primary determinant of outcomes.
How Can Psychedelic Therapy be Accessed in Canada?
In Canada, regulated psychedelic compounds are accessible through frameworks established by Health Canada. A growing number of licensed practitioners connected to our clinic network across the country are working within these regulatory pathways to provide this care. If you’re a therapist interested in offering psychedelic therapy support to your clients, we’d love to hear from you.
Click here to learn more about our training.
Curious whether psychedelic therapy might be right for you? Take the first step and book a free Info Call with the ATMA CENA team.
